Laboratory Corporation of America Holdings Company Profile (NYSE:LH)

About Laboratory Corporation of America Holdings (NYSE:LH)

Laboratory Corporation of America Holdings logoLaboratory Corporation of America Holdings is a life sciences company that is integrated in guiding patient care, providing clinical laboratory and end-to-end drug development services. The Company operates as a healthcare diagnostics company. The Company operates through two segments: LabCorp Diagnostics (LCD) and Covance Drug Development (CDD). The LCD segment is an independent clinical laboratory business, which offers menu of frequently requested and specialty testing through an integrated network of primary and specialty laboratories across the United States. The CDD segment offers drug development services, and provides a range of drug research and development (R&D) and market access services to biopharmaceutical companies and medical device companies across the world. It serves a range of customers, including managed care organizations (MCOs), biopharmaceutical companies, governmental agencies, physicians and other healthcare providers.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Healthcare Facilities & Services
  • Sub-Industry: Health Care Services
  • Symbol: NYSE:LH
  • CUSIP: 50540R40
  • Web: www.labcorp.com
Capitalization:
  • Market Cap: $15.22928 billion
  • Outstanding Shares: 101,800,000
Average Prices:
  • 50 Day Moving Avg: $153.32
  • 200 Day Moving Avg: $148.94
  • 52 Week Range: $119.51 - $164.22
P/E:
  • Trailing P/E Ratio: 20.96
  • Foreward P/E Ratio: 14.30
  • P/E Growth: 1.75
Sales & Book Value:
  • Annual Revenue: $9.67 billion
  • Price / Sales: 1.58
  • Book Value: $57.63 per share
  • Price / Book: 2.60
Profitability:
  • EBITDA: $1.86 billion
  • Net Margins: 7.57%
  • Return on Equity: 16.85%
  • Return on Assets: 6.55%
Debt:
  • Debt-to-Equity Ratio: 0.95%
  • Current Ratio: 1.39%
  • Quick Ratio: 1.28%
Misc:
  • Average Volume: 635,273 shs.
  • Beta: 0.92
  • Short Ratio: 3.29
 

Frequently Asked Questions for Laboratory Corporation of America Holdings (NYSE:LH)

What is Laboratory Corporation of America Holdings' stock symbol?

Laboratory Corporation of America Holdings trades on the New York Stock Exchange (NYSE) under the ticker symbol "LH."

How were Laboratory Corporation of America Holdings' earnings last quarter?

Laboratory Corporation of America Holdings (NYSE:LH) posted its earnings results on Wednesday, July, 26th. The company reported $2.47 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $2.40 by $0.07. The business had revenue of $2.50 billion for the quarter, compared to analyst estimates of $2.47 billion. Laboratory Corporation of America Holdings had a net margin of 7.57% and a return on equity of 16.85%. The business's quarterly revenue was up 4.9% on a year-over-year basis. During the same quarter in the previous year, the business posted $2.36 EPS. View Laboratory Corporation of America Holdings' Earnings History.

When will Laboratory Corporation of America Holdings make its next earnings announcement?

Laboratory Corporation of America Holdings is scheduled to release their next quarterly earnings announcement on Wednesday, October, 25th 2017. View Earnings Estimates for Laboratory Corporation of America Holdings.

What guidance has Laboratory Corporation of America Holdings issued on next quarter's earnings?

Laboratory Corporation of America Holdings issued an update on its FY17 earnings guidance on Wednesday, July, 26th. The company provided earnings per share guidance of $9.30-9.65 for the period, compared to the Thomson Reuters consensus EPS estimate of $9.43. The company issued revenue guidance of +5.0-6.5% to ~9.91-10.05 billion, compared to the consensus revenue estimate of $9.86 billion.

Where is Laboratory Corporation of America Holdings' stock going? Where will Laboratory Corporation of America Holdings' stock price be in 2017?

13 brokerages have issued 1 year price targets for Laboratory Corporation of America Holdings' shares. Their predictions range from $138.00 to $190.00. On average, they expect Laboratory Corporation of America Holdings' share price to reach $168.00 in the next year. View Analyst Ratings for Laboratory Corporation of America Holdings.

What are analysts saying about Laboratory Corporation of America Holdings stock?

Here are some recent quotes from research analysts about Laboratory Corporation of America Holdings stock:

  • 1. According to Zacks Investment Research, "Over the last three months LabCorp has been trading above the broader industry. Over the past few quarters, the company delivered promising top-line growth on strong Diagnostics business. However, unimpressive performance within Covance Drug Development is quite disappointing. As per LabCorp, the impact of the cancellation by sponsors of two large clinical studies in late 2016 affected the results in this phase. This apart, an unfavorable foreign exchange continues to hamper overall result. Yet, an increased 2017 guidance boosted investors’ confidence indicating chances of respite anytime soon. We believe that with the integration of newer acquisitions, LabCorp is perfectly positioned to drive long-term profitable growth. We are also upbeat about the company's recent acqusition of Chiltern, a specialty CRO for an all-cash transaction valued at roughly $1.2 billion." (10/10/2017)
  • 2. Canaccord Genuity analysts commented, "LH bounced back from an underwhelming Q3 with a good Q4 that beat our/consensus estimates on the top and bottom lines. The 2017 guide is what we expected and we believe sets an appropriate bar for the company to execute against. LH spent a good portion of time on its call (in the Q&A) defending its strategic planning and responded to questions about its reported interest (Reuters) to acquire NC-based CRO Pharmaceutical Product Development (PPD) for ~$8 billion. While on one hand the deal would make sense to bolster its Covance business, our sense from investors is that most would prefer to see LH return more of its capital to shareholders in the form of share repurchases, which LH re-initiated in Q4. Regardless, we think the stock is cheap and it remains one of our five top picks for 2017 as we expect "mean-reverted" multiple expansion and another solid year of FCF (~$975M, or $9.43/sh.) and strong capital deployment. BUY. We raise our estimates and PT to $150 from $140." (2/17/2017)
  • 3. Mizuho analysts commented, "We are raising our price target to $139 ($135 previously) post 4Q on betterthan-expected cash flow guidance. We are maintaining our 2017E and 2018E adjusted EPS estimates of $9.65 and $10.32, respectively. LH reported a good 4Q and initial 2017 guidance despite some noise. The company also noted a more conservative approach to its CRO metrics, which we view favorably." (2/17/2017)

Who are some of Laboratory Corporation of America Holdings' key competitors?

Who are Laboratory Corporation of America Holdings' key executives?

Laboratory Corporation of America Holdings' management team includes the folowing people:

  • David P. King, Chairman of the Board, President, Chief Executive Officer
  • Glenn A. Eisenberg, Chief Financial Officer, Executive Vice President
  • John D. Ratliff, Chief Executive Officer - Covance Drug Development
  • Lisa J. Uthgenannt, Chief Human Resource Officer
  • Edward T. Dodson, Senior Vice President, Chief Accounting Officer, Principal Accounting Officer
  • Lance V. Berberian, Senior Vice President, Chief Information Officer
  • F. Samuel Eberts III, Senior Vice President, Chief Compliance Officer, Secretary, Chief Legal Officer
  • Robert E. Mittelstaedt Jr., Lead Independent Director
  • Kerrii B. Anderson, Independent Director
  • Jean-Luc Belingard, Independent Director

Who owns Laboratory Corporation of America Holdings stock?

Laboratory Corporation of America Holdings' stock is owned by a variety of of institutional and retail investors. Top institutional investors include Eqis Capital Management Inc. (0.01%). Company insiders that own Laboratory Corporation of America Holdings stock include David P King, Edward T Dodson, F Samuel Eberts III, Glenn A Eisenberg, James T Jr Boyle, Jean-Luc Belingard, Lance Berberian, Lisa J Uthgenannt, R Sanders Williams and Robert E Mittelstaedt Jr. View Institutional Ownership Trends for Laboratory Corporation of America Holdings.

Who bought Laboratory Corporation of America Holdings stock? Who is buying Laboratory Corporation of America Holdings stock?

Laboratory Corporation of America Holdings' stock was acquired by a variety of institutional investors in the last quarter, including Eqis Capital Management Inc.. View Insider Buying and Selling for Laboratory Corporation of America Holdings.

How do I buy Laboratory Corporation of America Holdings stock?

Shares of Laboratory Corporation of America Holdings can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Laboratory Corporation of America Holdings' stock price today?

One share of Laboratory Corporation of America Holdings stock can currently be purchased for approximately $149.67.


MarketBeat Community Rating for Laboratory Corporation of America Holdings (NYSE LH)
Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  304 (Vote Outperform)
Underperform Votes:  364 (Vote Underperform)
Total Votes:  668
MarketBeat's community ratings are surveys of what our community members think about Laboratory Corporation of America Holdings and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Laboratory Corporation of America Holdings (NYSE:LH) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 5 Hold Ratings, 8 Buy Ratings
Consensus Rating:Buy (Score: 2.62)
Consensus Price Target: $168.00 (12.25% upside)
Consensus Price Target History for Laboratory Corporation of America Holdings (NYSE:LH)
Price Target History for Laboratory Corporation of America Holdings (NYSE:LH)
Analysts' Ratings History for Laboratory Corporation of America Holdings (NYSE:LH)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
10/12/2017SunTrust Banks, Inc.Reiterated RatingBuy$190.00N/AView Rating Details
10/12/2017Wells Fargo & CompanyInitiated CoverageMarket Perform -> Outperform$175.00N/AView Rating Details
9/26/2017KeyCorpReiterated RatingHoldLowView Rating Details
9/17/2017Robert W. BairdReiterated RatingNeutral -> HoldLowView Rating Details
9/13/2017Jefferies Group LLCReiterated RatingHold$157.00 -> $170.00MediumView Rating Details
9/11/2017Canaccord GenuityReiterated RatingBuy$175.00 -> $180.00MediumView Rating Details
8/10/2017Morgan StanleyBoost Price TargetOverweight$154.00 -> $166.00LowView Rating Details
7/27/2017Barclays PLCBoost Price TargetOverweight$182.00 -> $183.00LowView Rating Details
7/27/2017Craig HallumReiterated RatingBuy$157.00 -> $179.00MediumView Rating Details
7/13/2017Credit Suisse GroupDowngradeHold$146.00LowView Rating Details
2/17/2017MizuhoBoost Price TargetNeutral$135.00 -> $139.00N/AView Rating Details
1/18/2017Deutsche Bank AGReiterated RatingBuy$170.00N/AView Rating Details
10/25/2016GabelliInitiated CoverageBuy$180.00N/AView Rating Details
9/9/2016Citigroup Inc.Initiated CoverageNeutral$156.00N/AView Rating Details
7/27/2016Evercore ISIBoost Price TargetBuy$147.00 -> $155.00N/AView Rating Details
3/23/2016Goldman Sachs Group, Inc. (The)Boost Price Target$119.00N/AView Rating Details
3/4/2016William BlairReiterated RatingOutperformN/AView Rating Details
2/19/2016Royal Bank Of CanadaLower Price TargetSector Perform$135.00 -> $130.00N/AView Rating Details
2/4/2016Raymond James Financial, Inc.Lower Price TargetOutperform$145.00 -> $135.00N/AView Rating Details
12/17/2015Stifel NicolausDowngradeBuy -> HoldN/AView Rating Details
(Data available from 10/17/2015 forward)

Earnings

Earnings History for Laboratory Corporation of America Holdings (NYSE:LH)
Earnings by Quarter for Laboratory Corporation of America Holdings (NYSE:LH)
Earnings History by Quarter for Laboratory Corporation of America Holdings (NYSE LH)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/25/2017$2.44N/AView Earnings Details
7/26/2017Q2 2017$2.40$2.47$2.47 billion$2.50 billionViewN/AView Earnings Details
4/25/2017Q1 2017$2.19$2.22$2.41 billion$2.41 billionViewN/AView Earnings Details
2/16/2017Q416$2.13$2.15$2.35 billion$2.39 billionViewListenView Earnings Details
10/26/2016Q316$2.29$2.25$2.38 billion$2.40 billionViewListenView Earnings Details
7/27/2016Q216$2.30$2.31$2.33 billion$2.40 billionViewListenView Earnings Details
4/25/2016Q116$1.96$2.02$2.19 billion$2.30 billionViewListenView Earnings Details
2/18/2016Q415$1.99$1.98$2.22 billion$2.24 billionViewListenView Earnings Details
10/26/2015Q315$2.07$2.07$2.25 billion$2.30 billionViewListenView Earnings Details
7/28/2015Q215$2.03$2.09$2.22 billion$2.20 billionViewListenView Earnings Details
4/27/2015Q115$1.63$1.73$1.79 billion$1.80 billionViewListenView Earnings Details
2/20/2015Q4$1.63$1.65$1.49 billion$1.51 billionViewListenView Earnings Details
10/28/2014Q3$1.75$1.80$1.56 billion$1.55 billionViewListenView Earnings Details
7/18/2014Q214$1.77$1.84$1.50 billion$1.52 billionViewN/AView Earnings Details
4/28/2014Q114$1.58$1.51$1.45 billion$1.43 billionViewListenView Earnings Details
2/7/2014Q413$1.66$1.61$1.46 billion$1.44 billionViewListenView Earnings Details
10/18/2013Q313$1.80$1.80$1.45 billion$1.46 billionViewListenView Earnings Details
7/19/2013Q2 2013$1.80$1.80$1.46 billion$1.47 billionViewListenView Earnings Details
4/19/2013Q1 2013$1.77$1.74$1.45 billion$1.44 billionViewListenView Earnings Details
2/8/2013Q4 2012$1.62$1.54$1.39 billion$1.41 billionViewListenView Earnings Details
10/18/2012$1.74$1.76ViewN/AView Earnings Details
7/19/2012$1.76$1.77ViewN/AView Earnings Details
4/19/2012$1.67$1.74ViewN/AView Earnings Details
2/10/2012$1.41$1.46ViewN/AView Earnings Details
10/20/2011$1.50$1.61ViewN/AView Earnings Details
7/21/2011$1.53$1.64ViewN/AView Earnings Details
4/21/2011$1.46$1.52ViewN/AView Earnings Details
2/10/2011$1.31$1.34ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Laboratory Corporation of America Holdings (NYSE:LH)
2017 EPS Consensus Estimate: $9.39
2018 EPS Consensus Estimate: $10.45
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20174$2.16$2.26$2.22
Q2 20175$2.41$2.50$2.46
Q3 20175$2.13$2.46$2.38
Q4 20175$2.01$2.45$2.33
Q1 20183$2.34$2.42$2.39
Q2 20183$2.63$2.75$2.70
Q3 20183$2.66$2.74$2.70
Q4 20183$2.65$2.68$2.66
Q1 20191$2.60$2.60$2.60
Q2 20191$2.99$2.99$2.99
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Laboratory Corporation of America Holdings (NYSE:LH)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Laboratory Corporation of America Holdings (NYSE:LH)
Insider Ownership Percentage: 0.90%
Institutional Ownership Percentage: 92.97%
Insider Trades by Quarter for Laboratory Corporation of America Holdings (NYSE:LH)
Institutional Ownership by Quarter for Laboratory Corporation of America Holdings (NYSE:LH)
Insider Trades by Quarter for Laboratory Corporation of America Holdings (NYSE:LH)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/6/2017David P KingCEOSell44,687$156.86$7,009,602.82View SEC Filing  
9/5/2017David P. KingCEOSell132,713$157.06$20,843,903.78View SEC Filing  
8/25/2017F Samuel Eberts IIIInsiderSell31,500$155.22$4,889,430.00View SEC Filing  
8/11/2017R Sanders WilliamsDirectorSell3,100$156.88$486,328.00View SEC Filing  
8/1/2017Glenn A EisenbergCFOSell5,968$159.46$951,657.28View SEC Filing  
8/1/2017Lisa J. UthgenanntInsiderSell5,000$160.00$800,000.00View SEC Filing  
5/22/2017Lance BerberianSVPSell3,613$139.84$505,241.92View SEC Filing  
5/9/2017Jean-Luc BelingardDirectorSell992$142.19$141,052.48View SEC Filing  
3/9/2017Glenn A EisenbergCFOSell2,300$142.47$327,681.00View SEC Filing  
2/24/2017Robert E Mittelstaedt JrDirectorSell5,300$142.69$756,257.00View SEC Filing  
8/9/2016Lisa J UthgenanntInsiderSell1,177$140.00$164,780.00View SEC Filing  
8/4/2016Glenn A EisenbergCFOSell8,000$140.10$1,120,800.00View SEC Filing  
8/4/2016Robert E Mittelstaedt JrDirectorSell992$140.15$139,028.80View SEC Filing  
6/13/2016David P KingCEOSell196,400$128.00$25,139,200.00View SEC Filing  
4/27/2016Edward T DodsonInsiderSell9,392$126.42$1,187,336.64View SEC Filing  
3/31/2016F Samuel Eberts IIIInsiderSell4,219$116.85$492,990.15View SEC Filing  
3/31/2016James T Jr. BoyleCEOSell18,132$116.81$2,117,998.92View SEC Filing  
3/14/2016F Samuel Eberts IIIInsiderSell309$115.32$35,633.88View SEC Filing  
3/14/2016James T Jr. BoyleCEOSell1,543$115.32$177,938.76View SEC Filing  
2/25/2016Jean-Luc BelingardDirectorSell1,296$109.74$142,223.04View SEC Filing  
2/16/2016F Samuel Eberts IIIInsiderSell370$103.02$38,117.40View SEC Filing  
2/16/2016James T. Jr. BoyleCEOSell4,055$103.02$417,746.10View SEC Filing  
2/12/2016F Samuel Eberts IIIinsiderSell405$101.67$41,176.35View SEC Filing  
2/12/2016James T. Jr. BoyleCEOSell2,712$101.67$275,729.04View SEC Filing  
1/8/2016F Samuel Eberts IIIInsiderSell1,215$119.05$144,645.75View SEC Filing  
12/8/2015F Samuel Eberts IIIInsiderSell1,010$123.31$124,543.10View SEC Filing  
11/2/2015R Sanders WilliamsDirectorSell1,850$124.30$229,955.00View SEC Filing  
7/1/2015David P KingCEOSell50,000$121.78$6,089,000.00View SEC Filing  
4/29/2015Jean-Luc BelingardDirectorSell1,542$123.10$189,820.20View SEC Filing  
4/23/2015James T Jr. BoyleCEOSell1,394$126.56$176,424.64View SEC Filing  
3/31/2015Mark E BrecherCMOSell20,625$126.98$2,618,962.50View SEC Filing  
3/30/2015Mark E BrecherCMOSell20,278$126.98$2,574,900.44View SEC Filing  
3/3/2015James T Jr. BoyleCOOSell1,237$123.70$153,016.90View SEC Filing  
2/13/2015James T Jr. BoyleCOOSell6,597$116.68$769,737.96View SEC Filing  
9/22/2014David P KingCEOSell65,234$104.71$6,830,652.14View SEC Filing  
9/5/2014R Sanders WilliamsDirectorSell2,000$107.95$215,900.00View SEC Filing  
8/22/2014David P KingCEOSell65,233$106.10$6,921,221.30View SEC Filing  
7/22/2014David P KingCEOSell65,233$105.55$6,885,343.15View SEC Filing  
6/9/2014James T Jr. BoyleCOOSell38,600$103.00$3,975,800.00View SEC Filing  
5/7/2014M Keith WeikelDirectorSell1,984$98.28$194,987.52View SEC Filing  
3/28/2014James Jr. BoyleCOOSell2,521$98.36$247,965.56View SEC Filing  
3/7/2014William HayesCFOSell23,848$94.40$2,251,251.20View SEC Filing  
2/13/2014James Jr. BoyleCOOSell4,123$90.29$372,265.67View SEC Filing  
2/11/2014James Jr. BoyleCOOSell1,204$91.15$109,744.60View SEC Filing  
1/27/2014David KingCEOSell24,200$90.15$2,181,630.00View SEC Filing  
12/24/2013David KingCEOSell25,000$90.79$2,269,750.00View SEC Filing  
10/24/2013David P KingCEOSell25,000$100.91$2,522,750.00View SEC Filing  
10/17/2013James T Jr. BoyleCOOSell24,400$102.00$2,488,800.00View SEC Filing  
9/25/2013David KingCEOSell25,000$99.06$2,476,500.00View SEC Filing  
8/26/2013David KingCEOSell25,000$96.60$2,415,000.00View SEC Filing  
8/21/2013Robert Mittelstaedt, Jr.DirectorSell7,429$96.86$719,572.94View SEC Filing  
7/24/2013David P KingCEOSell25,000$97.72$2,443,000.00View SEC Filing  
6/24/2013David P KingCEOSell25,000$98.66$2,466,500.00View SEC Filing  
6/7/2013James T Jr. BoyleCOOSell63,100$99.63$6,286,653.00View SEC Filing  
5/28/2013Mark E BrecherInsiderSell16,900$100.92$1,705,548.00View SEC Filing  
5/21/2013William B HayesCFOSell127,200$100.00$12,720,000.00View SEC Filing  
5/17/2013F Samuel Eberts IIIInsiderSell10,000$98.47$984,700.00View SEC Filing  
5/10/2013James T Jr. BoyleCOOSell68,908$93.82$6,464,948.56View SEC Filing  
5/8/2013Jean-Luc BelingardDirectorSell2,536$92.88$235,543.68View SEC Filing  
4/11/2013William B HayesCFOSell22,234$95.00$2,112,230.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Laboratory Corporation of America Holdings (NYSE:LH)
Latest Headlines for Laboratory Corporation of America Holdings (NYSE:LH)
Source:
DateHeadline
finance.yahoo.com logoCovance Recognized with Frost & Sullivan Asia Pacific CRO Customer Value Leadership Award
finance.yahoo.com - October 16 at 7:57 PM
americanbankingnews.com logoWells Fargo & Company Begins Coverage on Laboratory Corporation of America Holdings (LH)
www.americanbankingnews.com - October 15 at 8:31 AM
americanbankingnews.com logoComparing Laboratory Corporation of America Holdings (LH) and Its Competitors
www.americanbankingnews.com - October 13 at 10:32 AM
americanbankingnews.com logoLaboratory Corporation of America Holdings (LH) Earns Buy Rating from SunTrust Banks, Inc.
www.americanbankingnews.com - October 12 at 7:32 PM
americanbankingnews.com logoLaboratory Corporation of America Holdings (LH) Receives Consensus Rating of "Buy" from Analysts
www.americanbankingnews.com - October 12 at 4:44 AM
americanbankingnews.com logoLaboratory Corporation of America Holdings (LH) Upgraded to Buy by Zacks Investment Research
www.americanbankingnews.com - October 10 at 10:14 AM
bizjournals.com logoHow LabCorp is becoming a life sciences superpower
www.bizjournals.com - October 9 at 4:27 PM
americanbankingnews.com logoAir Methods Corp (AIRM) vs. Laboratory Corporation of America Holdings (LH) Head-To-Head Contrast
www.americanbankingnews.com - October 6 at 2:32 AM
bizjournals.com logoPlanet LabCorp: How the Burlington company is becoming a life sciences superpower - Triad Business Journal
www.bizjournals.com - October 5 at 8:18 AM
bizjournals.com logoTechnical Snapshots for These Medical Research Stocks -- VWR Corp., China Cord Blood, Laboratory Corp. of America, and Quest Diagnostics
www.bizjournals.com - October 2 at 12:23 PM
finance.yahoo.com logoShould Value Investors Pick Laboratory Corporation (LH) Stock?
finance.yahoo.com - October 2 at 12:23 PM
americanbankingnews.com logoLaboratory Corporation of America Holdings (LH) Expected to Post Earnings of $2.42 Per Share
www.americanbankingnews.com - September 29 at 10:40 AM
nasdaq.com logoCommit To Buy Laboratory Corporation of America Holdings At $135, Earn 4.1% Annualized Using Options - Nasdaq
www.nasdaq.com - September 27 at 3:55 PM
bizjournals.com logoHow proposed cuts to Medicare reimbursement rates could impact LabCorp - Triad Business Journal
www.bizjournals.com - September 27 at 10:15 AM
americanbankingnews.com logoHead to Head Survey: Laboratory Corporation of America Holdings (LH) versus The Competition
www.americanbankingnews.com - September 27 at 4:28 AM
finance.yahoo.com logoLaboratory Corporation of America Holdings -- Moody's: Proposed Medicare Lab Rate Cuts Would be Credit Negative for LabCorp
finance.yahoo.com - September 26 at 5:45 PM
finance.yahoo.com logoHow proposed cuts to Medicare reimbursement rates could impact LabCorp
finance.yahoo.com - September 26 at 5:45 PM
americanbankingnews.com logoKeyCorp Reiterates "Hold" Rating for Laboratory Corporation of America Holdings (LH)
www.americanbankingnews.com - September 26 at 5:38 PM
americanbankingnews.com logoFinancial Analysis: Laboratory Corporation of America Holdings (LH) versus Tenet Healthcare Corporation (THC)
www.americanbankingnews.com - September 26 at 12:32 PM
americanbankingnews.com logoLifePoint Health (LPNT) & Laboratory Corporation of America Holdings (LH) Head to Head Survey
www.americanbankingnews.com - September 26 at 10:16 AM
barrons.com logoQuest Diagnostics: Will It Fail The Test? - Barron's
www.barrons.com - September 26 at 9:37 AM
nasdaq.com logoMonday Sector Laggards: Technology & Communications, Healthcare
www.nasdaq.com - September 25 at 7:01 PM
finance.yahoo.com logoLabCorp Objects to Proposed PAMA 2018 Medicare Payment Rates for Clinical Laboratory Tests; Calls for Delay in Implementation to Avoid Significant Harm to Medicare Beneficiaries
finance.yahoo.com - September 25 at 7:01 PM
finance.yahoo.com logoThe Big Loser: Quest Diagnostics Quits
finance.yahoo.com - September 25 at 7:01 PM
americanbankingnews.com logoSunTrust Banks Comments on Laboratory Corporation of America Holdings' Q3 2017 Earnings (LH)
www.americanbankingnews.com - September 20 at 6:36 AM
americanbankingnews.com logoLaboratory Corporation of America Holdings to Post Q1 2019 Earnings of $2.60 Per Share, SunTrust Banks Forecasts (LH)
www.americanbankingnews.com - September 19 at 11:38 AM
americanbankingnews.com logoHead to Head Comparison: Laboratory Corporation of America Holdings (LH) and Its Peers
www.americanbankingnews.com - September 18 at 8:34 PM
bizjournals.com logoLabCorp amends credit facility to $1 billion
www.bizjournals.com - September 18 at 7:57 PM
americanbankingnews.com logoLaboratory Corporation of America Holdings (LH) Stock Rating Reaffirmed by Robert W. Baird
www.americanbankingnews.com - September 17 at 7:42 AM
americanbankingnews.com logoLaboratory Corporation of America Holdings (LH) Receives Consensus Recommendation of "Buy" from Brokerages
www.americanbankingnews.com - September 17 at 4:40 AM
seekingalpha.com logoLabCorp expands credit facility - Seeking Alpha
seekingalpha.com - September 15 at 8:29 PM
finance.yahoo.com logoLaboratory Corp. of America Holdings breached its 50 day moving average in a Bearish Manner : LH-US : September 14, 2017
finance.yahoo.com - September 15 at 5:42 AM
finance.yahoo.com logoLabCorp Presents Nine Studies, Including Novel Research on Improving Genetic Counseling Quality, at the National Society of Genetic Counselors Annual Conference
finance.yahoo.com - September 15 at 5:42 AM
americanbankingnews.com logoLaboratory Corporation of America Holdings (LH) to Post Q1 2018 Earnings of $2.41 Per Share, William Blair Forecasts
www.americanbankingnews.com - September 14 at 10:31 AM
americanbankingnews.com logoQ3 2017 EPS Estimates for Laboratory Corporation of America Holdings (LH) Boosted by Jefferies Group
www.americanbankingnews.com - September 14 at 6:56 AM
americanbankingnews.com logoJefferies Group LLC Reiterates Hold Rating for Laboratory Corporation of America Holdings (LH)
www.americanbankingnews.com - September 13 at 9:52 AM
americanbankingnews.com logoFY2017 EPS Estimates for Laboratory Corporation of America Holdings Boosted by Analyst (LH)
www.americanbankingnews.com - September 13 at 8:30 AM
americanbankingnews.com logo$2.53 Billion in Sales Expected for Laboratory Corporation of America Holdings (LH) This Quarter
www.americanbankingnews.com - September 12 at 6:06 AM
americanbankingnews.com logoLaboratory Corporation of America Holdings (LH) Rating Increased to Top Pick at Canaccord Genuity
www.americanbankingnews.com - September 11 at 8:22 AM
finance.yahoo.com logoLabCorp Named Among “The World’s Most Innovative Companies” in Forbes’ 2017 Ranking
finance.yahoo.com - September 8 at 1:17 AM
americanbankingnews.com logoLaboratory Corporation of America Holdings (LH) CEO Sells $7,009,602.82 in Stock
www.americanbankingnews.com - September 7 at 4:24 PM
americanbankingnews.com logoInsider Selling: Laboratory Corporation of America Holdings (LH) CEO Sells 132,713 Shares of Stock
www.americanbankingnews.com - September 7 at 1:26 PM
finance.yahoo.com logoDynacare Acquires Hooper-Holmes Canada Ltd.
finance.yahoo.com - September 6 at 9:37 PM
finance.yahoo.com logoLabCorp is Scheduled to Present at the Morgan Stanley Global Healthcare Conference
finance.yahoo.com - September 5 at 3:57 PM
finance.yahoo.com logoLaboratory Corp. of America Holdings breached its 50 day moving average in a Bullish Manner : LH-US : September 4, 2017
finance.yahoo.com - September 4 at 7:12 PM
finance.yahoo.com logoLabCorp Completes Acquisition of Chiltern
finance.yahoo.com - September 2 at 5:12 AM
finance.yahoo.com logoThe National Football League Alumni Association, Cancer Treatment Centers of America® and LabCorp Team Up to Offer Prostate Cancer Screenings Starting in September
finance.yahoo.com - August 31 at 6:51 AM
bizjournals.com logoN.C. firms land on Forbes' list of the most innovative companies in the world
www.bizjournals.com - August 30 at 5:53 AM
americanbankingnews.com logoF Samuel Eberts III Sells 31,500 Shares of Laboratory Corporation of America Holdings (LH) Stock
www.americanbankingnews.com - August 29 at 4:14 PM
bizjournals.com logoTriad firm lands on Forbes' list of the most innovative companies in the world - Triad Business Journal
www.bizjournals.com - August 29 at 1:07 AM

Social

Chart

Laboratory Corporation of America Holdings (LH) Chart for Tuesday, October, 17, 2017

This page was last updated on 10/17/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.